Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

A. Murumagi; A. Hirasawa; S. Khan; M. Arjama; T. Pellinen; R. Koivisto-Korander; A. Leminen; A. Magi; T. Aittokallio; R. Butzow; O. Kallioniemi

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

A. Murumagi, A. Hirasawa, S. Khan, M. Arjama, T. Pellinen, R. Koivisto-Korander, A. Leminen, A. Magi, T. Aittokallio, R. Butzow, O. Kallioniemi

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	International Journal of Gynecological Cancer
Volume	26
Pages (from-to)	653-653
Number of pages	1
ISSN	1048-891X
Publication status	Published - Oct 2016
MoE publication type	Not Eligible

Cite this

Murumagi, A., Hirasawa, A., Khan, S., Arjama, M., Pellinen, T., Koivisto-Korander, R., Leminen, A., Magi, A., Aittokallio, T., Butzow, R., & Kallioniemi, O. (2016). Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells. International Journal of Gynecological Cancer, 26, 653-653.

@article{eacfa814eb514645a52aa91eb3ea4aec,

title = "Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells",

author = "A. Murumagi and A. Hirasawa and S. Khan and M. Arjama and T. Pellinen and R. Koivisto-Korander and A. Leminen and A. Magi and T. Aittokallio and R. Butzow and O. Kallioniemi",

year = "2016",

month = oct,

language = "English",

volume = "26",

pages = "653--653",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc. ",

}

Murumagi, A, Hirasawa, A, Khan, S , Arjama, M, Pellinen, T, Koivisto-Korander, R, Leminen, A, Magi, A, Aittokallio, T , Butzow, R & Kallioniemi, O 2016, 'Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells', International Journal of Gynecological Cancer, vol. 26, pp. 653-653.

TY - JOUR

T1 - Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells

AU - Murumagi, A.

AU - Hirasawa, A.

AU - Khan, S.

AU - Arjama, M.

AU - Pellinen, T.

AU - Koivisto-Korander, R.

AU - Leminen, A.

AU - Magi, A.

AU - Aittokallio, T.

AU - Butzow, R.

AU - Kallioniemi, O.

PY - 2016/10

Y1 - 2016/10

M3 - Meeting Abstract

SN - 1048-891X

VL - 26

SP - 653

EP - 653

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

ER -